Anita Saraf

Dr. Anita Saraf

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in International Journal of Cardiology
Verified
Journal Article
Closed access
ASAnita Saraf
Anita Saraf
CSChristine De Staercke
Christine De Staercke
IEIan Everitt
Ian Everitt
AHAlice Haouzi
Alice Haouzi
YKYi-An Ko
Yi-An Ko
WBWendy Book
Wendy Book

1 April 2021 in Stem Cell Research
Verified
Journal Article
Open access
ASAnita Saraf
Anita Saraf
ARAntonio Rampoldi
Antonio Rampoldi
MCMyra Chao
Myra Chao
DLDong Li
Dong Li
LALawrence Armand
Lawrence Armand
CXChunhui Xu
Chunhui Xu
Proinflammatory molecule tumor necrosis factor alpha (TNF-α) is predominantly elevated in cytokine storm as well as worsening cardiac function. Here we model the molecular and functional effects of TNF-α in cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC). We found that treatment of hiPSC-CMs with TNF-α increased reactive oxygen species (ROS) and caspase 3/7 activity and caused cell death and apoptosis. TNF-α treatment also resulted in dysregulation of cardiomyocyte function with respect to the increased abnormal calcium handling, calcium wave propagation between cells and excitation-contraction coupling. We also uncovered significant changes in gene expression and protein localization caused by TNF-α treatment. Notably, TNF-α treatment altered the expression of ion channels, dysregulated cadherins, and affected the localization of gap-junction protein connexin-43. In addition, TNF-α treatment up-regulated IL-32 (a human specific cytokine, not present in rodents and an inducer of TNF-α) and IL-34 and down-regulated glutamate receptors and cardiomyocyte contractile proteins. These findings provide insights into the molecular and functional consequences from the exposure of human cardiomyocytes to TNF-α. Our study provides a model to incorporate inflammatory factors into hiPSC-CM-based studies to evaluate mechanistic aspects of heart disease.

1 October 2019 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
ASAnita Saraf
Anita Saraf
WBWendy M. Book
Wendy M. Book
TNTimothy J. Nelson
Timothy J. Nelson
CXChunhui Xu
Chunhui Xu

3 August 2024 in International Journal of Cardiology
Verified
Journal Article
Open access
CBCarley Bright
Carley Bright
ARAfshan Rizvi
Afshan Rizvi
FEFrancis Ezekwueme
Francis Ezekwueme
MSMary Schiff
Mary Schiff
JKJennifer Kliner
Jennifer Kliner
ASAnita Saraf
Anita Saraf
Guideline-directed heart failure therapy with angiotensin receptor blocker/neprilysin inhibitor (ARNi) and sodium-glucose transporter inhibitors (SGLT2i) has been incrementally beneficial in improving outcomes in heart failure patients. Evaluate the feasibility and efficacy of guideline-directed medical therapy (GDMT) in adults congenital heart disease (ACHD) patients. In a retrospective cohort study, ACHD patients with either New York Heart Association (NYHA) Class II symptoms or systemic ejection fraction (EF) <45%, optimized on a combination of beta-blocker (BB), ARNi, mineralocorticoid receptor antagonist (MRA) and SGLT2i were evaluated. Forty-six patients with a mean age 42.6 ± 12.1 years prescribed GDMT were identified. Twenty-eight (61%) were male, 20 (43%) had a systemic right ventricle (RV) and 9 (20%) had single-ventricle physiology. Over the optimization period, 20 (43%) were sustained on ARNi and 42 (91%) on SGLT2i in addition to treatment with BB and MRA. Over a period of 45 weeks, echocardiography parameters for left ventricle (LV) ejection fraction (EF) (+7.5%, p = 0.006), systemic ventricle (SV) velocity time integral (VTI) (+1.9 cm, p = 0.012) and LV global longitudinal strain (GLS) (-2.5%, p = 0.005) improved when 3-4 medications were used versus 1-2 medications alone. The use of either ARNi or SGLT2i (+8.1%, p = 0.017) or in combination (+7.0%, p = 0.043) increased LVEF compared to the use of neither medication. Combination GDMT is beneficial in improving myocardial characteristics in ACHD patients with systemic RV and LV.

17 August 2023 in Clinical Transplantation
Verified
Journal Article
Closed access
GHGavin Hickey
Gavin Hickey
CRCharith Ratnayake
Charith Ratnayake
AEAndrea Elliot
Andrea Elliot
TATarek Alsaied
Tarek Alsaied
AFAnthony Fabio
Anthony Fabio
ASAnita Saraf
Anita Saraf

27 June 2025 in Therapeutics
Verified
Journal Article
Open access
PDF file
JLJordann Lewis
Jordann Lewis
BYBasil Yaseen
Basil Yaseen
HWHaodi Wu
Haodi Wu
ASAnita Saraf
Anita Saraf
Background: Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) allow for high-throughput evaluation of cardiomyocyte (CM) physiology in health and disease. While multimodality testing provides a large breadth of information related to electrophysiology, contractility, and intracellular signaling in small populations of iPSC-CMs, current technologies for analyzing these parameters are expensive and resource-intensive. Methods: We have designed a novel 2D/3D hybrid organoid system that can harness optical imaging techniques to assess electromechanical properties and calcium dynamics across CMs in a high-throughput manner. We validated our methods using a doxorubicin-based system, as the drug has well-characterized cardiotoxic, pro-arrhythmic effects. Results: This novel hybrid system provides the functional benefit of 3D organoids while minimizing optical interference from multilayered cellular systems through our cell-culture techniques that propagate organoids outwards into 2D iPSC-CM sheets. The organoids recapitulate contractile forces that are more robust in 3D structures and connectivity, while 2D CMs facilitate analysis at an individual cellular level, which recreated numerous doxorubicin-induced electrophysiologic and propagation abnormalities. Conclusions: Thus, we have developed a novel 2D/3D hybrid organoid model that employs an integrated optical analysis platform to provide a reliable high-throughput method for studying cardiotoxicity, providing valuable data on calcium, contractility, and signal propagation.